Management emphasized growing use of AI-powered tools within its clinician network, signaling deeper engagement that could support long-term healthcare platform goals.

Analysts note a balance between investing in AI, managing costs, and evolving regulations, which could cap overall value capture even as guidance improves.

NOHARM-backed physician-review, via PeerCheck, underpins AI safety and helps create a moat as AI outputs are continually corrected by clinicians.

Investors reevaluated the stock’s valuation, moving from near multi-year lows as AI investments shifted from a margin concern to a growth catalyst.

Doximity posted fiscal Q1 2027 results with revenue of $156.6 million and adjusted EBITDA of $74.8 million, both topping consensus and guiding full-year revenue to $671-$681 million, about 5% higher.

Stock moved sharply higher in premarket trading as CEO highlighted profitability of the new AI search tool, with the shares briefly more than doubling.

Adjusted EPS came in at $0.29 on revenue of $156.6 million, up about 7% year over year, as the market focused more on AI adoption and performance than on a minor earnings miss.

Near-term rally drivers include recognizing AI Search revenue in Q3, NOHARM outcomes from peer review, and monetization of Scribe platform through enterprise deals.

Regulatory backdrop includes FDA easing AI oversight for clinical decision support, but 15+ new state laws in 2026 require clinician review of AI recommendations, adding ongoing risk for AI vendors.

Longer-term growth narratives show a 5-year revenue CAGR of 21.9% and a 2-year growth rate of 15.2%, with consensus for about 3.6% next year, highlighting AI-driven acceleration as key.

The broader market was modestly positive; the rally was driven mainly by solid results, higher guidance, and tangible AI traction rather than macro factors alone.

AI initiatives propelled the rally, with Doximity Ask ranking top among U.S.-based models on the NOHARM benchmark and AI Search gaining momentum with pharma clients as a potential revenue driver.